Allarity Therapeutics, Inc. Repayments of Bank Debt
Allarity Therapeutics, Inc. (ALLR) reported Repayments of Bank Debt of $2.93 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfBankDebt · last filed 2022-11-14
- Allarity Therapeutics, Inc. repayments of bank debt for the quarter ending 2021-09-30 was -$10.00K.
| Period end | Repayments of Bank Debt 3 month | Repayments of Bank Debt 6 month | Repayments of Bank Debt 9 month |
|---|---|---|---|
| 2021-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.93M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $2.94M 10-Q · filed 2022-10-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |